Related Experiment Videos
Neuropeptides in neurological tumours
Journal of Neuro-Oncology
|January 1, 1985
Summary
Neuropeptide concentrations varied in human brain tumors. Better differentiated astrocytomas showed higher levels of five neuropeptides compared to poorly differentiated ones, with high bombesin in metastases.
Area of Science:
- Neuroscience
- Oncology
- Biochemistry
Background:
- Neuropeptides play crucial roles in neurological functions.
- Understanding neuropeptide expression in brain tumors is vital for diagnosis and treatment.
- Tumor differentiation and origin may influence neuropeptide profiles.
Purpose of the Study:
- To quantify concentrations of seven neuropeptides in human neurological tumors.
- To investigate the relationship between neuropeptide levels and tumor differentiation.
- To analyze neuropeptide profiles in metastatic brain tumors.
Main Methods:
- Analysis of neuropeptide concentrations in 69 human neurological tumor samples.
- Categorization of tumors based on differentiation (Grade I/II astrocytomas vs. poorly differentiated).
- Examination of neuropeptide levels in metastatic tumors, including those from oat cell carcinoma.
Main Results:
- Higher concentrations of neuropeptide Y, somatostatin, substance P, vasoactive intestinal peptide, and cholecystokinin were found in well-differentiated astrocytomas (Grade I/II) compared to poorly differentiated tumors.
- Metastatic tumors, particularly those from oat cell carcinoma of the bronchus, exhibited very high concentrations of bombesin.
Conclusions:
- Neuropeptide expression patterns differ based on the degree of tumor differentiation in astrocytomas.
- Bombesin may serve as a significant marker in metastatic tumors originating from oat cell carcinoma.
- These findings contribute to the understanding of neurochemical alterations in brain tumors.